ProCE Banner Activity

Cardiovascular Risk Reduction Strategies With GLP-1 Receptor Agonists


Download this slideset to review strategies on how to develop tailored and comprehensive treatment plans for patients with diabetes requiring cardiovascular risk reduction using GLP-1 RAs.

Released: September 14, 2023



Darren K. McGuire

Darren K. McGuire, MD, MHSc, FACC

Distinguished Teaching Professor of Medicine
Jere H. Mitchell, MD Distinguished Chair in Cardiovascular Science
Division of Cardiology, Department of Medicine
University of Texas Southwestern Medical Center
Dallas, Texas

Anne Peters

Anne Peters, MD

USC Clinical Diabetes Programs
Professor of Clinical Medicine
Keck School of Medicine of USC
University of Southern California
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


This activity is supported by an educational grant from Novo Nordisk.

Novo Nordisk